https://doi.org/10.1016/S2214-109X(16)00071-1. PMID: 27102194.

2. Radhakrishnan J., Remuzzi G., Saran R. et al. Taming the chronic kidney disease epidemic: A global view of surveillance efforts. Kidney Int. 2014; 86(2): 246–50.

https://doi.org/10.1038/ki.2014.190. PMID: 24897034. PMCID: PMC4593485.

3. Шишкова В.Н. Хроническая болезнь почек и сердечно-сосудистая заболеваемость: фокус на фибрилляцию предсердий. Рациональная фармакотерапия в кардиологии. 2015; 11(2): 196–201 (Shishkova V.N. Chronic kidney disease and cardiovascular morbidity: focus on atrial fibrillation. Racional’naya farmakoterapiya v kardiologii = Rational Pharmacotherapy in Cardiology. 2015; 11(2): 196–201 (In Russ.)).

https://doi.org/10.20996/1819-6446-2015-11-2-196-201. EDN: TQTHWV.

4. Snively C.S., Gutierrez C. Chronic kidney disease: Prevention and treatment of common complications. Am Fam Physician. 2004; 70(10): 1921–28. PMID: 15571058.

5. Manjunath G., Tighiouart H., Coresh J. et al. Level of kidney function as a risk factor for cardiovascular outcomes in the elderly. Kidney Int. 2003; 63(3): 1121–29.

https://doi.org/10.1046/j.1523-1755.2003.00838.x. PMID: 12631096.

6. GBD Causes of Death Collaborators. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: A systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017; 390(10100): 1151–1210.

https://doi.org/10.1016/S0140-6736(17)32152-9. PMID: 28919116. PMCID: PMC5605883.

7. GBD Mortality Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: A systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015; 385(9963): 117–71.

https://doi.org/10.1016/S0140-6736(14)61682-2. PMID: 25530442. PMCID: PMC4340604.

8. Lozano R., Naghavi M., Foreman K. et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the global burden of disease study 2010. Lancet. 2012; 380(9859): 2095–2128.

https://doi.org/10.1016/S0140-6736(12)61728-0. PMID: 23245604. PMCID: PMC10790329.

9. Bikbov B., Purcell C., Levey A. et al. Global, regional, and national burden of chronic kidney disease, 1990–2017: A systematic analysis for the global burden of disease study 2017. Lancet. 2020; 395(10225): 709–33.

https://doi.org/10.1016/S0140-6736(20)30045-3. PMID: 32061315. PMCID: PMC7049905.

10. Foreman K.J., Marquez N., Dolgert A. et al. Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: Reference and alternative scenarios for 2016-40 for 195 countries and territories. Lancet. 2018; 392(10159): 2052–90.

https://doi.org/10.1016/S0140-6736(18)31694-5. PMID: 30340847. PMCID: PMC6227505.

11. Rhee C.M., Kovesdy C.P. Epidemiology: Spotlight on CKD deaths-increasing mortality worldwide. Nat Rev Nephrol. 2015; 11(4): 199–200.

https://doi.org/10.1038/nrneph.2015.25. PMID: 25734769. PMCID: PMC4379111.

12. Weiner D.E. Public health consequences of chronic kidney disease. Clin Pharmacol Ther. 2009; 86(5): 566–69.

https://doi.org/10.1038/clpt.2009.137. PMID: 19641489. PMCID: PMC2788514.

13. Banik S., Ghosh A. Prevalence of chronic kidney disease in Bangladesh: A systematic review and meta-analysis. 2021; 53(4): 713–18.

https://doi.org/10.1007/s11255-020-02597-6. PMID: 32789568.

14. Seck S.M., Doupa D., Gueye L. et al. Prevalence of chronic kidney disease and associated factors in senegalese populations: A community-based study in Saint-Louis. Nephrourol Mon. 2014; 6(5): e19085.

https://doi.org/10.5812/numonthly.19085. PMID: 25695030. PMCID: PMC4318016.

15. GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990–2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2020; 395(10225): 709–33.

https://doi.org/10.1016/S0140-6736(20)30045-3. PMID: 32061315. PMCID: PMC7049905.

16. Mills K.T., Xu Y., Zhang W. et al. A systematic analysis of worldwide population-based data on the global burden of chronic kidney disease in 2010. Kidney Int. 2015; 88(5): 950–57.

https://doi.org/10.1038/ki.2015.230. PMID: 26221752. PMCID: PMC4653075.

17. Hill N.R., Fatoba S.T., Oke J.L. et al. Global prevalence of chronic kidney disease – a systematic review and meta-analysis. PLoS One. 2016; 11(7): e0158765.

https://doi.org/10.1371/journal.pone.0158765. PMID: 27383068. PMCID: PMC4934905.

18. Jager K.J., Kovesdy C., Langham R. et al. A single number for advocacy and communication-worldwide more than 850 million individuals have kidney diseases. Kidney Int. 2019; 96(5): 1048–50.

https://doi.org/10.1016/j.kint.2019.07.012. PMID: 31582227.

19. Клинические рекомендации. Хроническая болезнь почек (ХБП). Ассоциация нефрологов. Рубрикатор клинических рекомендаций Минздрава России. 2021. ID: 469. Доступ: http://cr.rosminzdrav.ru/schema/469_2 (дата обращения – 12.09.2024). (Clinical guidelines. Chronic kidney disease (CKD). Association of Nephrologists. Rubricator of clinical guidelines of the Ministry of Healthcare of Russia. 2021. ID: 469. URL: http://cr.rosminzdrav.ru/schema/469_2 (date of access – 12.09.2024) (In Russ.)).

20. Бикбов Б.Т., Томилина Н.А. Заместительная терапия больных с хронической почечной недостаточностью в Российской Федерации в 1998–2011 гг. (Отчет по данным Российского регистра заместительной почечной терапии. Часть первая). Нефрология и диализ. 2014; 16(1): 11–127. (Bikbov B.T., Tomilina N.A. Replacement therapy of patients with chronic renal failure in the Russian Federation in 1998–2011 (Report on the data of the Russian Register of Renal Replacement Therapy. Part One). Nefrologiya i dializ = Nephrology and Dialysis. 2014; 16(1): 11–127 (In Russ.)). EDN: SCXWNL.

21. Есаян А.М., Арутюнов Г.П., Мелихов О.Г. Распространенность хронической болезни почек среди пациентов, обратившихся в учреждения первичной медико-санитарной помощи. Результаты проспективного наблюдательного исследования в 12 регионах России. Клиническая нефрология. 2021; 13(3): 6–16. (Yesayan A.M., Arutyunov G.P., Melikhov O.G. Prevalence of chronic kidney disease among patients presenting to primary health care. Results of a prospective observational study in 12 regions of Russia. Klinicheskaya nefrologiya = Clinical Nephrology. 2021; 13(3): 6–16 (In Russ.)).

https://doi.org/10.18565/nephrology.2021.3.6-16. EDN: RFKKZF.

22. Кобалава Ж.Д., Виллевальде С.В., Багманова Н.Х. с соавт. Распространенность маркеров хронической болезни почек у пациентов с артериальной гипертонией в зависимости от наличия СД: результаты эпидемиологического исследования ХРОНОГРАФ. Российский кардиологический журнал. 2018; 23(2): 91–101. (Kobalava Zh.D., Villevalde S.V., Bagmanova N.Kh. et al. The prevalence of markers of chronic kidney disease in patients with arterial hypertension depending on the presence of diabetes mellitus: Results of the CHRONOGRAPH epidemiological study. Rossijskiy kardiologicheskiy zhurnal = Russian Journal of Cardiology. 2018; 23(2): 91–101 (In Russ.)).

https://doi.org/10.15829/1560-4071-2018-2-91-101. EDN: YRGRAE.

23. Шамхалова М.Ш., Викулова О.К., Железнякова А.В. с соавт. Эпидемиология хронической болезни почек в Российской Федерации по данным Федерального регистра взрослых пациентов с сахарным диабетом (2013–2016 гг.). Сахарный диабет. 2018; 21(3): 160–169. (Shamkhalova M.Sh., Vikulova O.K., Zheleznyakova A.V. et al. Epidemiology of chronic kidney disease in the Russian Federation according to the Federal Register of Adult Patients with Diabetes Mellitus (2013–2016). Saharnyy diabet = Diabetes Mellitus. 2018; 21(3): 160–169 (In Russ.)).

https://doi.org/10.14341/DM9687. EDN: XYEBFB.

24. Liyanage T., Toyama T., Hock-ham C. et al. Prevalence of chronic kidney disease in Asia: A systematic review and analysis. BMJ Glob Health. 2022; 7(1): e007525.

https://doi.org/10.1136/bmjgh-2021-007525. PMID: 35078812. PMCID: PMC8796212.

25. Hasan M., Sutradhar I., Gupta R.D., Sarker M. Prevalence of chronic kidney disease in South Asia: A systematic review. BMC Nephrol 19. 2018; 19(1): 291.

https://doi.org/10.1186/s12882-018-1072-5. PMID: 30352554. PMCID: PMC6199753.

26. Zhang L., Long J., Jiang W. et al. Trends in chronic kidney disease in China. N Engl J Med. 2016; 375(9): 905–6.

https://doi.org/10.1056/NEJMc1602469. PMID: 27579659.

27. Li G., Huang J., Wang J. et al. Long-term exposure to ambient PM2.5 and increased risk of CKD prevalence in China. J Am Soc Nephrol. 2021; 32(2): 448–58.

https://doi.org/10.1681/ASN.2020040517. PMID: 33334736. PMCID: PMC8054885.

28. Collins A.J., Foley R.N., Gilbertson D.T., Chen S.C. United States Renal Data System public health surveillance of chronic kidney disease and end-stage renal disease. Kidney Int Suppl (2011). 2015; 5(1): 2–7.

https://doi.org/10.1038/kisup.2015.2. PMID: 26097778. PMCID: PMC4455192.

29. Wen H., Yang D., Xie C. et al. Comparison of trend in chronic kidney disease burden between China, Japan, the United Kingdom, and the United States. Front Public Health. 2022; 10: 999848.

https://doi.org/10.3389/fpubh.2022.999848. PMID: 36159316. PMCID: PMC9499831.

30. Johansen K.L., Chertow G.M., Gilbertson D.T. et al. US Renal Data System 2021 Annual Data Report: Epidemiology of kidney disease in the United States. Am J Kidney Dis. 2022; 79(4 Suppl 1): A8–A12.

https://doi.org/10.1053/j.ajkd.2022.02.001. PMID: 35331382. PMCID: PMC8935019.

31. Australian Institute of Health and Welfare. Profiles of Aboriginal and Torres Strait Islander people with kidney disease. Cat. no. IHW 229. Canberra, ACT: AIHW, 2020.

32. Bello K., Ronksley P.E., Tangri N. et al. Prevalence and demographics of CKD in Canadian primary care practices: A cross-sectional study. 2019; 4(4): 561–70.

https://doi.org/10.1016/j.ekir.2019.01.005. PMID: 30993231. PMCID: PMC6451150.